CEO Harith Rajagopalan buys 25,000 GUTS shares at $0.73; stock now at $0.72, down 76.2% from 52-week high amid weak fundamentals and cluster buying.
Harith Rajagopalan, Chief Executive Officer of Fractyl Health, purchased 25,000 shares at $0.73 on 2026-06-10, bringing his holdings to 540,557 shares post-transaction. The stock now trades at $0.72, representing a 76.2% decline from its 52-week high of $3.03, though it has recovered 54.7% over the past 90 days from deeper lows. Critically, the company faces severe fundamentals: annual revenue growth is -100.0% (latest quarter revenue of $14.0K), and the company was unprofitable over its most recent full fiscal year despite a reported net income of $9.2M in the most recent quarter. His prior buy at this ticker on 2025-12-04 delivered a 90-day return of -74.0%, and his cross-ticker track record shows zero wins at the 90-day mark with an average 90-day return of -74.0%. A cluster of 3 other insiders also bought within the past 14 days, though this does not alter the pattern of weak execution on his part and deteriorating company financials.